Avandia Heart Risks Buried by Drug Company

The pharmacy company that makes the popular diabetes drug Avandia, SmithKline Beecham, knew for over a decade that the drug caused an increased risk of heart problems – but covered up the information according to a report published in the New York Times.

The Times report said that SmithKline did not post results of its drug trial findings on its website or submit them to federal regulators. This information was based on internal company documents it obtained.

According to a March 21, 2001 email the Times obtained, a company executive wrote about the study results:

“This was done for the U.S. business, way under radar. Per Sr. Mgmt request, these data should not see the light of day to anyone outside of GSK.” (GlaxoSmith Kline is the corporate successor to SmithKline)

Today, FDA panel will begin determining what to do about Avandia. More than half a million Americans have been prescribed Avandia, but the covered up studies issue that the drug have linked it to a raised risk of stroke, heart attack, and even death.

For more information please call 1877 MESSALAW.